Altoida is a groundbreaking pioneer at the forefront of digital biomarker development for neurological diseases, harnessing the power of augmented reality and machine learning. Their cutting-edge technology platform is meticulously engineered to provide an unbiased assessment of an individual's cognitive and functional capabilities, pinpoint symptomatic impairments resulting from amyloid pathology, and even predict the potential progression towards Alzheimer's disease.

In the realm of brain health, Altoida is forging an entirely new standard through Precision Neurology. They are revolutionizing the way we gauge brain function and diagnose neurological conditions, all with the convenience of your smartphone or tablet.

With a robust foundation built on over two decades of groundbreaking research in digital biomarkers, augmented reality (AR), and artificial intelligence (AI), Altoida stands as a leader in this evolving field.